Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors DOI
Bin Zhang, Zhikun Liu,

Shengjin Xia

et al.

European Journal of Medicinal Chemistry, Journal Year: 2021, Volume and Issue: 216, P. 113300 - 113300

Published: Feb. 21, 2021

Language: Английский

Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy DOI
Zigao Yuan, Shaopeng Chen,

Qinsheng Sun

et al.

Bioorganic & Medicinal Chemistry, Journal Year: 2017, Volume and Issue: 25(15), P. 4100 - 4109

Published: May 31, 2017

Language: Английский

Citations

77
Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency DOI
Ahmed M. Shawky, Mohammed A. S. Abourehab, Ashraf N. Abdalla

et al.

European Journal of Medicinal Chemistry, Journal Year: 2019, Volume and Issue: 185, P. 111780 - 111780

Published: Oct. 13, 2019

Language: Английский

Citations

62
Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective DOI Creative Commons
Yuan Gao, Hang Zhang, Frédéric Lirussi

et al.

Biochemical Pharmacology, Journal Year: 2020, Volume and Issue: 182, P. 114224 - 114224

Published: Sept. 19, 2020

Language: Английский

Citations

60
Microtubule associated proteins as targets for anticancer drug development DOI

Sadiya Khwaja,

Kapil Kumar,

Ranjana Das

et al.

Bioorganic Chemistry, Journal Year: 2021, Volume and Issue: 116, P. 105320 - 105320

Published: Aug. 31, 2021

Language: Английский

Citations

47
Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors DOI
Bin Zhang, Zhikun Liu,

Shengjin Xia

et al.

European Journal of Medicinal Chemistry, Journal Year: 2021, Volume and Issue: 216, P. 113300 - 113300

Published: Feb. 21, 2021

Language: Английский

Citations

46